Asia Pacific In-vitro Toxicology Testing Market Size & Outlook
Asia Pacific in-vitro toxicology testing market, 2018-2030 (US$M)
Related Markets
Asia Pacific in-vitro toxicology testing market highlights
- The Asia Pacific in-vitro toxicology testing market generated a revenue of USD 4,096.8 million in 2023.
- The market is expected to grow at a CAGR of 11% from 2024 to 2030.
- In terms of segment, pharmaceutical industry was the largest revenue generating end user in 2023.
- Diagnostics is the most lucrative end user segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 4,096.8 million |
| Market revenue in 2030 | USD 8,513.8 million |
| Growth rate | 11% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceutical industry |
| Fastest growing segment | Diagnostics |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
| Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 13.2% of the global in-vitro toxicology testing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 32,265.4 million by 2030.
Pharmaceutical industry was the largest segment with a revenue share of 43.36% in 2023. Horizon Databook has segmented the Asia Pacific in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific market is expected to grow at the fastest CAGR during the forecast period. The overall regional growth can be attributed to countries such as China, India, and South Korea. China In vitro toxicology testing market is estimated to be the largest revenue-generating market, while India is projected to witness the fastest growth rate.
The launch of a substantial number of initiatives across the region is anticipated to positively impact the entities involved in toxicology testing. One such entity that is likely to be benefitted is the Singapore-based TÜV SÜD PSB, which offers testing and product certification services including in vitro toxicology services.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Toxicology Testing Market Scope
In-vitro Toxicology Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific in-vitro toxicology testing market size, by country, 2018-2030 (US$M)
Asia Pacific In-vitro Toxicology Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
